Dr. Marcie Lynn Wolinsky-friedland, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 111 Clock Tower Cmns, Brewster, NY 10509 Phone: 845-279-5187 |
News Archive
The growing use of rapid response teams dispatched by hospitals to evaluate patients whose conditions have suddenly deteriorated may be masking systemic problems in how hospitals care for their sickest patients, says a prominent Johns Hopkins patient safety expert.
Researchers from the University of California San Diego School of Medicine have found a way to create new neurons in a mouse model of Parkinson's disease. The severely debilitating and progressive neurodegenerative disease, as of now, has no cure, and this breakthrough could help hundreds of thousands of patients with the condition feel experts.
Human leukocyte antigen alleles not only increase susceptibility to multiple sclerosis, but also influence the course of the disease, suggests research.
Pfizer Inc. announced today that, in the interest of patient safety, it is voluntarily withdrawing ThelinĀ® (sitaxentan) for the treatment of pulmonary arterial hypertension (PAH) in regions where it is approved (the European Union, Canada and Australia). In addition, Pfizer is discontinuing clinical studies of Thelin worldwide.
› Verified 5 days ago